No Data
No Data
Information on individual stocks.
Ecomot <3987.T> rapidly rebounded. A limit of 150,000 shares (2.85% of the issued shares excluding treasury stocks) and a treasury stock acquisition limit of 50 million yen were established. The acquisition period is from April 15 to August 31. Additionally, the first half financial results for this August period were announced, showing a consolidated operating profit of 44 million yen (14.7 times compared to the same period last year). The effects of promoting cost rate improvement measures and strengthening cost control are evident. Commerce One <4496.T> significantly continued to rise. A limit of 100,000 shares (1% of the issued shares excluding treasury stocks).
J. Front and others, announced Share Buyback on April 14.
The companies that announced their stock buyback plans on April 14 (Monday) are as follows: <3086> J Front 11.5 million shares (4.5%) 15 billion yen (from 25/4/15 to 25/8/29) <3087> Doutor Nichires 3.5 million shares (8.0%) 5 billion yen (from 25/4/15 to 25/10/14) <8273> Izumi 1 million shares (1.4%) 4 billion yen (on 25/4/15) <3479> TKP 3 million shares (7.1%) 3.5 billion yen (from 25/4/15 to 25/6/3)
Medurek, DWTI and others [Emerging Markets press release]
<4496> Commerce One has completed its acquisition of its own stocks. <4575> The period for the collaborative research agreement with the Pharma Valley project concerning CANVAS DO/TDO inhibitors has been extended. <4576> The approval application for DWTI's nerve pain treatment drug "DW-5LBT" has been accepted in the USA. <4586> Medreck MRX-5LBT: The approval application has been accepted by the USA FDA. <4884> Additional analysis of the Phase II clinical trial targeting ALS (physician-led clinical trial): Extended collaborative research with Tohoku University.
Beeplatts, QPS Research Institute and others.
LeTech <3497> has revised its Dividends forecast, suspending the year-end Dividends. Sumitomo Forestry <1911> has made a public tender offer at a price of 686 yen per share, which is expected to result in (Delisted) status post-tender offer. GeneXpert <4179> has amended its Financial Estimates, now anticipating an operating loss of △0.169 billion yen, revised from △1.40 to △0.1 billion yen. A mid-term management plan covering the period from March 2026 to March 2028 has been formulated, setting the operating profit target for March 2028 at 0.80 to 0.09 billion yen. BePlatz <4381> is involved in financial operations and the planning of corporate strategies.
Commerce One Holdings: Extraordinary Report
Commerce One Holdings To Go Ex-Dividend On March 28th, 2025 With 10 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Commerce One Holdings(4496.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 10 JPY dividend per share. The